^

Cebu News

PhilHealth hemodialysis coverage expanded

Mitchelle L. Palaubsanon - The Freeman
PhilHealth hemodialysis coverage expanded
According to PhilHealth, its members and their qualified dependents diagnosed with chronic kidney disease stage 5 (CKD5) needing hemodialysis as prescribed by their nephrologists may avail themselves of this benefit package.
STAR / File

CEBU, Philippines — The Philippine Health Insurance Corporation (PhilHealth) announced that its coverage for hemodialysis has been expanded from 90 to 156 sessions starting this year as provided for in PhilHealth Circular 2023-0009 entitled “Institutionalization of 156 hemodialysis sessions” which takes effect on June 22, 2023.

According to PhilHealth, its members and their qualified dependents diagnosed with chronic kidney disease stage 5 (CKD5) needing hemodialysis as prescribed by their nephrologists may avail themselves of this benefit package.

The patient, however, should also be registered in the PhilHealth Dialysis Database prior to availment.

The state-run health insurer explained that the total of 156 sessions is in accordance with the current standards for adequate hemodialysis of three sessions per week for 52 weeks which is equivalent to one year.

With this benefit expansion, CKD5 patients on hemodialysis can avail of as much as P405,600 per year at P2,600 per session.

PhilHealth President and CEO Emmanuel R. Ledesma, Jr. said, in a statement, that they are confident that this will adequately support Filipinos who need this life-saving treatment.

“Ang pagpapalawig ng benepisyo para sa hemodialysis ay patunay na ang PhilHealth ay nakikinig sa panawagan ng ating mga miyembro. Patuloy ang aming pag-aaral na mapabuti ang mga benepisyo ng PhilHealth upang mas mabigyan pa ng sapat na financial risk protection ang mga Filipino,” Ledesma added.

Ledesma also emphasized that the expansion in hemodialysis coverage as well as its institutionalization is made possible with the help of the Philippine Amusement and Gaming Corporation (PAGCOR) and Philippine Charity Sweepstakes Office (PCSO).

However, PhilHealth strongly advocates for peritoneal dialysis (PD) first, as it encourages accredited healthcare providers to recommend PD as the initial line of treatment for CKD5 patients.

On the other hand, kidney transplantation remains the gold standard treatment for patients with kidney failure.

The state agency added that it is set to increase financial coverage for its peritoneal dialysis and kidney transplantation packages in the next two years.

As such, all health facilities should register their newly diagnosed CKD Stage 5 patients needing renal replacement therapy in the PhilHealth Dialysis Database.

A total of P21 billion from the said partner agencies have already been approved for transfer to PhilHealth under the 2023 General Appropriations Act. — (FREEMAN)

vuukle comment

PHILHEALTH

Philstar
x
  • Latest
Latest
Latest
abtest
Are you sure you want to log out?
X
Login

Philstar.com is one of the most vibrant, opinionated, discerning communities of readers on cyberspace. With your meaningful insights, help shape the stories that can shape the country. Sign up now!

Get Updated:

Signup for the News Round now

FORGOT PASSWORD?
SIGN IN
or sign in with